Cyclazodone
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
(RS)-2-(cyclopropylamino)-5-phenyl-1,3-oxazol-4-one
|
|
| Clinical data | |
| Legal status |
|
| Routes of administration |
Oral |
| Identifiers | |
| CAS Number | 14461-91-7  |
| ATC code | None |
| PubChem | CID: 26701 |
| ChemSpider | 24875  |
| UNII | O8U55ZRL9K |
| ChEMBL | CHEMBL2106536 |
| Chemical data | |
| Formula | C12H12N2O2 |
| Molecular mass | 216.090 g/mol |
|
|
|
|
| (what is this?) (verify) |
Cyclazodone is a centrally acting stimulant drug developed by American Cyanamid Company in the 1960s.[1] The drug is related to other drugs such as pemoline and 4-methylaminorex. It is a banned stimulant under the World Anti-Doping Agency prohibited list.[2]
See also[edit]
References[edit]
- ^ US Patent 3,321,470 - 5-Arylidene-2Amino-2-Oxazolin-4-Ones
- ^ World Anti-Doping Agency 2008 Prohibited List
|
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
